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A procedure for the synthesis ofL-IX-vinylglycine from L-homoserine 
lactone is described. The route developed is convenient (only one 
chromatography step is required) and efficient (72 %; ;::: 95 % op-
tical yield over 4 steps). Key features include the use of acid-labile 
protecting groups for the amino (Boc) and carboxyl (diphenylmethyl 
ester) groups, and the use of the phenylselenolate equivalent derived 
from sodium borohydride and diphenyl diselenide for L-homoserine 
lactone cleavage. 
a-Vinylglycine, the simplest a-vinyl amino acid, occurs 
naturally in mushrooms. 1 This [3,y-unsaturated amino 
acid is an important mechanism-based inhibitor of a 
number of pyridoxal-linked enzymes. Five transamina-
ses, including those for L-aspartate, L-alanine, L-serine 
and D-alanine,2 - 6 have been shown to be inactivated by 
racemic vinylglycine. In the case of the D-amino acid 
transaminases, Soper et a1.4 noticed that only D-alanine, 
and not L-alanine, protected against inhibition and so 
presumed that D-vinylglycine was the actual suicide in-
hibitor. One decarboxylase, L-cysteine sulfinate decarb-
oxylase, is also known to be irreversibly inactivated by 
vinylglycine. 7 
Optically pure vinylglycine is also a versatile chiral buil-
ding block, as evidenced by the range of synthetic appli-
cations for which it has been employed. Rapoport and 
co-workers used D-vinylglycine as an important building 
block in the construction of the mitomycin core.8 Crisp 
and Glink described the synthesis of a number of inter-
esting chain-extended [3,y-unsaturated amino acids via 
Heck couplings of vinyl and aryl halides and triflates 
with suitably protected L-a-vinylglycine derivatives. 9 
Most recently, Huwe and Blechert reported a clever route 
to hydroxypyrrolidines that employs a ring-closing olefin 
metathesis of an N-allyl-L-a-vinylglycinol as the key 
step.10 
A number of syntheses of a-vinylglycine in both race-
micll and enantiomerically enriched form12 have been 
developed. As part of a program directed at the synthesis 
of unnatural, a-branched amino acids, we recently de-
scribed a general procedure for the formal a-vinylation 
of protected amino acids to produce higher (i. e. bearing 
a second a-R group in addition to the a-vinyl group) 
a-vinyl amino acids in racemic formY The key steps in 
our formal vinylation procedure are: (1) alkylation of an 
amino acid derived dianion with ethylene oxide as a vinyl 
cation equivalent to provide the corresponding a-substi-
tuted homo serine lactone/ 3 and (2) chemoselective alkyl 
cleavage of this y-Iactone through the agency of new 
non-reducing phenylselenolate equivalent developed in 
this work.14-16 
More recently, we have been investigating asymmetric 
versions of this methodology to access enantiomerically 
enriched a-vinyl amino acids. 1 7 The approaches being 
taken include the use of chiral dianions for the initial 
alkylation step18 and enzymatic resolution. 19 For vinyl-
glycine, however, the simplest and only a-unbranched 
member of this class, it seemed reasonable that we might 
be able to intersect our vinylation procedure at step two. 
Namely, we envisioned phenylselenolate-mediated lac-
tone cleavage as the key operation in the transformation 
of L-homoserine lactone into L-a-vinylglycine. Two im-
portant issues became apparent. (1) A suitable amino 
protecting group would need to be found that would 
withstand phenylselenolate anion at elevated tempera-
tures, yet be removable under mild conditions, following 
unveiling of the [3,y-unsaturated ester functionality. (2) 
Racemization was seen as a potential problem, particu-
larly in the first two steps from L-homoserine lactone: 
base-mediated amino group protection, and nucleophilic, 
phenylselenolate-mediated lactone cleavage. Optical pu-
rity would have to be assessed and, if necessary, condi-
tions modified to minimize racemization. 
We report here that these issues have been addressed and 
that the general approach envisioned has now been re-
duced to practice. An important feature of the successful 
procedure includes the use of Boc protection for the a-
amino group and diphenylmethyl ester protection for the 
a-carboxyl group, both of which may be removed quan-
titatively, under exceptionally mild conditions, in the final 
step. Another key element proved to be the choice of an 
appropriate phenylselenolate equivalent so as to prevent 
racemization in the lactone cleavage step. 
Thus, Boc protection of L-homoserine lactone proceeds 
smoothly to yield 1 in 97 % yield (Scheme). Lactone 1 is 
then cleaved with the phenylselenolate equivalent gen-
erated from sodium borohydride and diphenyl disele-
nide. 15a,15c,2o Gratifyingly, the Boc-amino protecting 
group survives these conditions quite well. This is signif-
icant as simple methyl carbamates are readily cleaved by 
sodium phenylselenolate anion. 15d The crude carboxylate 
salt is protonated and treated with diphenyldiazomethane 
in the workup to give phenylselenide 2 in 83 % yield and 
in ::2: 96% ee. 21 
On the other hand, use of the phenylselenolate equivalent 
derived from the reduction of diphenyl diselenide with 
sodium trimethoxyborohydride here is efficient (72 % 
yield after esterification with diphenyldiazomethane), but 
results in partial (8 -13 %) racemization. 21 Consonant 
with previous findings, then, it appears that the NaBH4 
derived reagent is best for unhindered lactones,15a,15c,2o 
whereas the chemoselective (non-reducing) NaHB(OMe)3 
derived reagent is of advantage for sterically hindered a-
branched lactones (for which racemization is also not an 
issue).13,14 
Ozone-mediated oxidation and pyrolysis of 2 under the 
previously reported conditions13 provides protected vin-
ylglycine derivative 3. Deprotection then ensues under 
very mild conditions. Specifically, treatment of 3 with 
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trifiuoroacetic acid, containing an equivalent of acetic 
acid as diphenylmethyl cation scavenger, at room tem-
perature gives L-ex-vinylglycine, as its trifiuoroacetate salt 
4 in 90 % yield for the final two steps. The final product 
is judged to be ;;::: 95 % ee, based upon integration of a 
1 H NMR spectrum of its Mosher amide, methyl ester. 23 
This synthesis ofL-ex-vinylglycine from L-homoserine lac-
tone is efficient (72 % over 4 steps) and quite 'convenient 
(only one column chromatography is required). Since D-
homo serine is also available commercially, the methodo-
logy described herein also constitutes a formal synthesis 
of D-ex-vinylglycine. 
Clear merits of this procedure for the synthesis of L-vin-
ylglycine are its convenience, chemical efficiency and 
ready reproducibility. From an economic point of view, 
the procedure is quite acceptable for preparing several 
grams of vinylglycine [L-Homoserine currently sells for 
$ 45/g (Aldrich) and is readily converted into the lac-
tone,24 whereas L-vinylglycine is priced at $ 330/50 mg 
(Sigma)], but becomes expensive for large scale work. 
This is in contrast to the procedure of Afzali-Ardakani 
and Rapoport12e,f which begins with L-methionine [$27/ 
100 g (Aldrich)], and to those of the Barton12b and Ha-
nessian12c groups which emanate from L-glutamic acid 
[$ 6/100 g]. To adapt the procedure described herein to 
large scale work, one could begin with L-methionine and 
convert it to L-homoserine, following Baldwin's "one-
pot" procedure (90 % yield). 25a Alternatively, it has been 
reported that L-asparagine [$23/100 g (Aldrich)] can be 
electrochemically reduced to L-homoserine in 71 % 
yield.25b 
SYNTHESIS 
All experimental procedures, analytical techniques and instruments 
employed were as previously described. 13 For NMR spectra of the 
final product, sodium 3-(trimethylsilyl)propanesulfonate was em-
ployed as an internal capiallary reference. Compounds 1-4 yielded 
satisfactory combustion analyses: C ± 0.25, H ± 0.25, N ± 0.15. 
N-(tert-Butoxycarbonyl)homoserine Lactone (1): 
To a solution of homoserine lactone, trifluoroacetate salt (2.00 g, 
9.29 mmol; readily obtained from L-homoserine)Z4,Z6 and Et3N 
(1.4 mL, 9.29 mmol) in CHzClz (38 mL) at O°C was added di-tert-
butyl dicarbonate (2.03 g, 9.29 mmol). The mixture was stirred for 
12 h at r. t. and washed with HzO (25 mL) an 1 N HCI (25 mL). 
The organic layer was dried (MgS04) and evaporated to give 
1 (1.82g, 97%) as a white solid; mp 111-113°C; [IXJb4 = + 8.16 
(c = 2.5, CHCI3). 
IHNMR (300 MHz, CDCI3): i5 = 1.44 (s, 9H), 2.16-2.25 (app 
quintet, J = 12 Hz, 1 H), 2.69-2.79 (m, 1 H), 4.18-4.28 (ddd, J = 5, 
9,11 Hz, 1 H), 4.29-4.38 (m, 1 H), 4.40-4.46 (app t, J = 9 Hz, 1 H), 
5.03-5.10 (m, 1 H). 
13C NMR (75 MHz, CDCI3): i5 = 28.1, 30.1, 50.0, 65.6, 80.3,155.4, 
175.4. 
IR (ATR): v = 3360 (br), 2981, 2931,1176, 1684cm- l . 
Diphenylmethyl N-(tert-Butoxycarbonyl)-2-(2' -(phenylseleno )ethyIJ-
glycinate (2): 
To an Ar-purged flask containing NaBH4 (310 mg, 8.19 mmol) was 
added a solution of PhzSez (1.58 g, 7.45 mmol) in DMF (60 mL) 
via cannula. To this solution was added, via cannula, a solution of 
lactone 1 (1.50 g, 7.45 mmol) in DMF (60 mL) and the mixture was 
heated at 100°C for 1 h. After cooling to O°C, MeOH (15 mL) was 
added and the crude mixture was stirred 5 h. The solvent was re-
moved in vacuo, and the residue was partitioned between EtzO 
(200 mL) and 100 mM NaOAc buffer (pH 5). The aqueous layer 
was extracted twice more with EtzO (200 mL), the combined organ-
ics were dried (MgS04), filtered, and esterified with diphenyldiazo-
methanez7 (1.88 g, 9.69 mmol) in EtOAc. Evaporation ofthe solvent 
and chromatography (0-15 % EtOAc/hexane) yielded 2 (3.24 g, 
83%) as a white solid; mp 108-110°C; [IXJb4 -12.28 (c = 2.9, 
CHCI3)· 
IH NMR (300 MHz, CDCI3): i5 = 1.42 (s, 9H), 1.96-2.06 (m, 1 H), 
2.17-2.25 (m, 1 H), 2.76-2.85 (m, 2H), 4.53-4.56 (app dd, J = 8, 
12 Hz, 1 H), 5.05-5.08 (d, J = 8 Hz, 1 H), 6.86 (s, 1 H), 7.20-7.45 
(m,15H). 
13C NMR (75 MHz, CDCI3): i5 = 22.93, 28.24, 33.31, 53.61, 78.05, 
80.01, 126.95, 127.07 (2C), 128.0, 128.1, 128.5, 128.6 (2C), 129.1, 
133.0, 139.4, 139.5, 155.2, 171.2. 
IR (ATR): v = 3370 (br), 2981, 1743, 1712 cm -I. 
Diphenylmethyl N-(tert-Butoxycarbonyl)-2-vinylglycinate (3) and 
IX-Vinylglycine, Trifluoroacetate Salt (4): 
Ozone was bubbled into a solution of selenide 2 (474 mg, 
0.913 mmol) in CHzClz (10 mL) at - 78°C until a light blue color 
persisted. After addition of hex-l-ene (2 mL, 16 mmol), this cold 
solution was added dropwise to refluxing benzene (36 mL) and the 
refluxing was continued for 1 h. Evaporation gave crude 3 as an 
oil. If desired, an analytical sample of 3 could be obtained by 
recrystallization (hexanes); mp 89-91 DC; [IXJb4 = -10.11 (c = 3.5, 
CHCI3)· 
IH NMR (300 MHz, CDCI3): i5 = 1.45 (s, 9H), 4.97-5.04 (m, 1 H), 
5.19-5.23 (d, J = 7 Hz, 1 H), 5.26-5.29 (d, J = 10 Hz, 1 H), 
5.33-5.39 (d, J = 18 Hz, 1 H), 5.89-6.00 (m, 1 H), 6.90 (s, 1 H), 
7.25- 7.42 (m, 10 H). 
13C NMR (75 MHz, CDCI3): l5 = 28.19, 55.88, 78.09, 79.98, 117.7, 
126.9, 127.1, 127.97, 128.04, 128.2, 128.5, 132.4, 139.39, 139.45, 
154.9, 169.71. 
IR (ATR): v = 3375 (br), 2977, 1743, 1711 cm -I. 
It was found to be most convenient, however, to deprotect crude 
3 without purification. To a solution of crude 3 in CHzClz (18 mL) 
at O°C were added CF3COzH (10 mL) and AcOH (57I1L, 
1.01 mmol). The mixture was allowed to warm to r. t. After 8 h at 
January 1996 
r. t. H 20 (30 mL) was added, followed by extraction with CH2Cl2 
(3 x 20 mL) and Et20 (3 x 20 mL). Evaporation of the aqueous 
layer, followed by thorough drying (50°ClO.5 Torr, P20 S sidearm) 
yielded 4 (176 mg, 90 % for two steps); [a]b4 = +'42.81 (c = 1.1, 
H 20). 
1 H NMR (300 MHz, D 20): c5 = 4.52-5.55 (d, J = 7 Hz, 1 H), 
5.48-5.50 (d, J = 5 Hz, 1 H), 5.53-5.54 (d, J = 2 Hz, 1 H), 
5.87-6.00 (ddd, J = 7,10,17 Hz, 1 H). 
BC NMR (75 MHz, D 20): c5 = 57.69,119.0 (q, J = 291 Hz), 125.7, 
130.6, 165.5 (q, J = 35 Hz), 173.1 
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